Cargando…
Building an Evidence Base on the Place of Industry-Sponsored Programs in Drug Safety Surveillance
Autor principal: | Arlett, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475507/ https://www.ncbi.nlm.nih.gov/pubmed/30637598 http://dx.doi.org/10.1007/s40264-018-00791-1 |
Ejemplares similares
-
The Costs of Industry-Sponsored Drug Trials in Canada
por: Tran, Dat T., et al.
Publicado: (2019) -
Industry - from sponsor to provider?
por: Griebenow, Reinhard
Publicado: (2017) -
Industry-sponsored economic studies in oncology vs studies sponsored by nonprofit organisations
por: Hartmann, M, et al.
Publicado: (2003) -
The path for medical associations to sponsor trustworthy guidelines:
is it feasible?
por: Pagano, Domenico, et al.
Publicado: (2022) -
Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor’s Perspective
por: Beyzarov, Elena, et al.
Publicado: (2020)